-
ACUITI
Study
EGAS50000000962
-
Evaluation of the ERa binding region activity in breast and endometrial cancer
Study
EGAS50000000009
-
STARR-seq of ERa binding sites in MCF7 and Ishikawa cell lines
Dataset
EGAD50000000015
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - WGS
Study
EGAS50000001082
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - Targeted
Study
EGAS50000001081
-
Enhancer profiling to identify identifies epigenetic markers of endocrine resistance in metastatic castration resistant prostate cancer patients
Study
EGAS00001006161
-
Multi-omic analyses from a randomized phase II study of epigenetic priming followed by nivolumab in previously treated metastatic non-small cell lung cancer
Study
EGAS50000000913
-
Study of biomarkers implicated in radio-immunotherapy response in metastatic cancer
Study
EGAS50000001149
-
Multi-omic dataset utilized in the analysis of a phase II study of epigenetic priming followed by nivolumab in lung cancer
Dataset
EGAD50000001336
-
Study of biomarkers implicated in radio-immunotherapy response in metastatic cancer
Dataset
EGAD50000001644
-
DAC for EGA study: Multi-omic analyses from a randomized phase II study of epigenetic priming followed by nivolumab in previously treated metastatic non-small cell lung cancer
Dac
EGAC50000000563
-
Identifying genetic variants that alter TCR usage in the peripheral repertoire
Study
EGAS00001008189
-
The dataset for Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Dataset
EGAD50000000744
-
Southern African Prostate Cancer Study (SAPCS) 70 whole bloods
Dataset
EGAD50000001626
-
DAC for Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Dac
EGAC50000000341
-
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients
Study
EGAS00001007072
-
INSPIRE - Investigator-initiated Phase 2 Study of Pembrolizumab Immunological Response in Metastatic Solid Tumors
Study
EGAS00001003280
-
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer (NABUCCO Cohorts 1 and 2)
Study
EGAS00001004521
-
Ultra-Low-Pass Whole Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma
Study
EGAS50000001027
-
Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in endometriod carcinomas
Study
EGAS50000001004
-
Diversity of U1 small nuclear RNAs and Evaluation of Diagnostic Methods for their Mutations
Study
EGAS50000000693
-
SCANDARE HNSCC
Study
EGAS50000001158
-
SCANDARE ovarian
Study
EGAS50000001161
-
SCANDARE ovarian WES data
Dataset
EGAD50000001658
-
Predicting resistance to chemotherapy using chromosomal instability signatures
Study
EGAS50000000992